@article{0779428a3047433ab9af7edf7cb92300,
title = "Use of Postexposure Prophylaxis after Occupational Exposure to Zaire ebolavirus",
abstract = "From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.",
keywords = "Ebola virus, TKM-Ebola, postexposure prophylaxis, vesicular stomatitis virus",
author = "Wong, {Karen K.} and Davey, {Richard T.} and Hewlett, {Angela L.} and Kraft, {Colleen S.} and Mehta, {Aneesh K.} and Mulligan, {Mark J.} and Allison Beck and William Dorman and Kratochvil, {Christopher J.} and Lilin Lai and Palmore, {Tara N.} and Susan Rogers and Smith, {Philip W.} and Suffredini, {Anthony F.} and Mark Wolcott and Ute Str{\"o}her and Uyeki, {Timothy M.}",
note = "Funding Information: Financial support. This work was supported by the CDC. The care of patients at the Emory Serious Communicable Diseases Unit was supported in part by the National Center for Advancing Translational Sciences of the NIH (award UL1TR000454). The care of patients at the NIH Clinical Center was funded by the NIAID. Publisher Copyright: {\textcopyright} 2016 Published by Oxford University Press for the Infectious Diseases Society of America 2016.",
year = "2016",
month = aug,
day = "1",
doi = "10.1093/cid/ciw256",
language = "English (US)",
volume = "63",
pages = "376--379",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "3",
}